26.12.2013 Views

Part-I - Controller General of Patents Designs and Trademarks

Part-I - Controller General of Patents Designs and Trademarks

Part-I - Controller General of Patents Designs and Trademarks

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(12) PATENT APPLICATION PUBLICATION (21) Application No.747/DEL/2011 A<br />

(19) INDIA<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application :17/03/2011 (43) Publication Date : 21/06/2013<br />

(54) Title <strong>of</strong> the invention : A GEMCITABINE BASED LIPOSOMAL FORMULATION FOR TREATMENT OF CANCER<br />

AND A PROCESS OF PREPARATION THEREOF<br />

(51) International classification :A61K<br />

(31) Priority Document No :NA<br />

(32) Priority Date :NA<br />

(33) Name <strong>of</strong> priority country :NA<br />

(86) International Application No<br />

:NA<br />

Filing Date<br />

:NA<br />

(87) International Publication No :NA<br />

(61) Patent <strong>of</strong> Addition to Application Number :NA<br />

Filing Date<br />

:NA<br />

(62) Divisional to Application Number<br />

:NA<br />

Filing Date<br />

:NA<br />

(71)Name <strong>of</strong> Applicant :<br />

1)COSMAS RESEARCH LAB LTD<br />

Address <strong>of</strong> Applicant :B-1/1446/10-B, Y-BLOCK<br />

CROSSING, HAMBRAN ROAD, LUDHIANA-141 001,<br />

PUNJAB, INDIA. Punjab India<br />

(72)Name <strong>of</strong> Inventor :<br />

1)DR. RAYASA RAMACHANDRA MURTHY<br />

2)DR. VENKATRAJU P. MAKAM<br />

3)SWATI G. PATEL<br />

(57) Abstract :<br />

A Gemcitabine based liposomal formulation for treatment <strong>of</strong> cancer <strong>and</strong> a process for preparing the same is disclosed, wherein<br />

said formulation comprises a lipid mixture, gemcitabine <strong>and</strong> optionally a folate lig<strong>and</strong>. Further, the lipid mixture comprises<br />

Hydrogenated soy phosphatidylcholine, cholesterol, <strong>and</strong> Digalactosyl diacylglycerol or Distearoylphosphatidylethanolamine. The<br />

molar ratio <strong>of</strong> Gemcitabine: lipid mixture is in the range <strong>of</strong> 1:4 to 1:6.<br />

No. <strong>of</strong> Pages : 48 No. <strong>of</strong> Claims : 20<br />

The Patent Office Journal 21/06/2013 13460

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!